martin e. gutierrez, md, regarding the implications of the initial & updated results of keynote 189
Published 5 years ago • 40 plays • Length 0:59
Download video MP4
Download video MP3
Similar videos
-
0:46
martin e. gutierrez, md, on treating non-squamous nsclc patients expressing high levels of pd-l1
-
1:18
ravi salgia, md, phd, on the ideal patient to receive alimta plus keytruda based on keynote-189
-
2:09
further: firmonertinib in nsclc with egfr pacc mutations
-
1:02
shirish madhav gadgeel, mbbs, on the ideal patient to receive alimta keytruda based on keynote-189
-
1:09
roy s. herbst, md, phd, on if keynote 189 impacted view of pdl-1 expression and patient selection
-
4:12
symptoms of brain tumors
-
52:59
total body pet revolution: impacting diagnostic medicine & medical research | dist prof simon cherry
-
5:24
focus on family after pancreatic cancer | living healthy chicago
-
13:07
investigator insights segment 1: targeting the c-met receptor as a therapeutic strategy in cancer
-
0:51
the link between processed meats, your microbiome, and colorectal cancer 🍖🔬
-
19:23
new approaches in metastatic pancreatic cancer
-
2:37
pancreatic cancer: can technology deliver a breakthrough?
-
24:10
early detection approaches for the family of gi cancers – 2020 stanford gastric cancer summit
-
44:32
webinar - new bli methods used to identify molecular drivers of cancer pathogenesis with dr. mazur
-
1:00
the future of cancer treatment (excerpt)
-
15:30
laura garcia bermejo - the european infrastructure for translational medicine: eatris
-
4:14
2022 patient summit highlights (english)
-
1:32
umn cancer bioengineering initiative: imaging
-
1:58
personalized medicine in cancer (excerpt)
-
0:38
tumor simultations offer insight into treatment options
-
7:24
greater cancer care is well-connected healthcare
-
1:50
meet radiation oncologist dr. carmen perez
Clip.africa.com - Privacy-policy